Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Ani Minasaryan
How to Become a Nobel Laureate: BIGR Analysis of 125 Years of Scientific Breakthroughs
Every October, the global scientific community pauses for a handful of phone calls from Stockholm. A sleepy professor in Boston or Kyoto answers a call from an unknown Swedish number, and in an instant, their life’s work is elevated to immortal status. When looking at the complete record of Nobel Laureates in Physiology or Medicine, it becomes clear that while raw genius is required, where that genius spends its time matters almost as much. Nobel-winning discoveries rarely happen in isolation.
Who Shaped Oncology in the First Half of 2026: Breaking Down Approvals by Indications
Key takeaways 22 FDA approvals 15 distinct indications 5 breast cancer approvals 8 blood cancers approvals This article focuses on where the 2026 approvals landed by their indications. The 22 approvals covered 15 distinct indications, with breast cancer leading the list with 5 approvals. Blood cancers received 8 approvals across 7 indications overall. Multiple myeloma, ovarian cancer, and bladder cancer got 2 approvals each.
Bayer Plans $2.2 Billion Ohio Manufacturing Campus to Support Oncology and Cardiorenal Portfolio
Announced on October 2, 2026, the multiyear project will be developed within the New Albany International Business Park and is expected to create around 600 permanent, highly skilled jobs. Bayer also anticipates approximately 1,500 construction jobs during the facility’s development. According to the company, the investment builds on more than $7 billion it has spent on pharmaceutical research, development, and manufacturing in the United States over the past five years.
Northeast GI Oncology Congress 2026: Bringing the GI Oncology Community Together
OncoDaily’s Northeast GI Oncology Congress 2026 will take place November 19–21 in Boston, Massachusetts, bringing clinicians, researchers, early-career investigators, and patient advocates into a shared discussion about the future of gastrointestinal cancer care. Over three days, the congress will connect scientific discovery with clinical practice, exploring how advances across GI cancers can inform treatment decisions, research priorities, and the patient experience.
Which Drugs and Pharma Shaped Oncology in the First Half of 2026? Breaking Down FDA Approvals
Key takeaways 22 FDA approvals 19 distinct drugs 16 pharma companies 5 first-time approvals This article focuses on each oncology approval in the first half of 2026 and where they came from: which company built the drug, which one owns it now, and how a therapy approved a decade ago can still be making headlines today. AstraZeneca had the most approvals in the first half of 2026: three credited to it directly, plus two ADCs it co-developed with Daiichi Sankyo.
Immuno 2026 Day 7 Highlights: Global Access to Immunotherapy and Education
The seventh and final day of the Immuno 2026 Global Virtual Congress on Immuno-Oncology, held on September 30, 2026, focused on global access to immunotherapy and education. The sessions looked at how scientific advances can become safe, affordable treatments for patients everywhere. They covered in vivo CAR T-cell therapy, cell therapy programs in Latin America, immunotherapy in resource-limited settings, the hidden toxicities of CAR T cells, and the WHO’s view of global access.
Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications
Teva Pharmaceutical Industries announced that the U.S. Food and Drug Administration (FDA) has approved denosumab-adet, a biosimilar to denosumab, across all indications of the reference product. The approval expands Teva’s biosimilar portfolio in oncology and bone health, providing a new treatment option for patients requiring denosumab-based therapy.
100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond
Since August 26, 2023, Women’s Equality Day in the United States has marked the beginning of a special OncoDaily tradition – the 100 Influential Women in Oncology. On this day, we launched an initiative to recognize 100 inspiring women making a difference in oncology around the world, highlighting 10 remarkable women each week.
100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond
Since August 26, 2023, Women’s Equality Day in the United States has marked the beginning of a special OncoDaily tradition – the 100 Influential Women in Oncology. On this day, we launched an initiative to recognize 100 inspiring women making a difference in oncology around the world, highlighting 10 remarkable women each week.
100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond
Since August 26, 2023, Women’s Equality Day in the United States has marked the beginning of a special OncoDaily tradition – the 100 Influential Women in Oncology. On this day, we launched an initiative to recognize 100 inspiring women making a difference in oncology around the world, highlighting 10 remarkable women each week.
100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond
Since August 26, 2023, Women’s Equality Day in the United States has marked the beginning of a special OncoDaily tradition – the 100 Influential Women in Oncology. On this day, we launched an initiative to recognize 100 inspiring women making a difference in oncology around the world, highlighting 10 remarkable women each week.
100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond
Since August 26, 2023, Women’s Equality Day in the United States has marked the beginning of a special OncoDaily tradition – the 100 Influential Women in Oncology. On this day, we launched an initiative to recognize 100 inspiring women making a difference in oncology around the world, highlighting 10 remarkable women each week.
100 Influential People in Oncology 2026 – Nominations are Open!
Welcome to OncoDaily’s official nomination form for 100 Influential People in Oncology 2026 powered by BIGR, including: 100 Key Opinion Leaders (KOLs) in Oncology in 2026 100 Oncology CEOs in 2026 100 AI Innovators in Oncology 2026 Rising Stars in Oncology 2026 We invite you to nominate outstanding individuals who are shaping the future of oncology through leadership, research, clinical excellence, innovation, mentorship, or advocacy.
100 Influential People in Oncology 2026 – Nominations are Open!
OncoDaily™ | © 2023 - 2025 All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Ani
Contact Ani, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack